E-poster No. / 壁報編號
C121
Title / 題目
Datopotamab deruxtecan for HR+HER2− advanced breast cancer: ADC sequencing, lines of therapy, and management of treatment-emergent adverse events—Insights from Japanese clinical experience
Authors / 作者群
Kaori Tane
1
2
;
Marina Kuniyasu
1
;
Koichi Hirokaga
1
;
Motoko Fujisaki
3
;
Yuki Sako
3
;
Miyuki Kawamura
3
;
Mitsunori Morita
3
;
Hirotaka Suto
3
;
Hideki Sakai
3
;
Takuma Onoe
3
;
Kyoko Ikeuchi
3
;
Koji Matsumoto
3
;
Seung Jin Kim
1
Affiliation / 服務單位
1.Department of Breast surgery, Hyogo Cancer Center, Akashi, Japan
2.Department of Breast Surgery, Kobe University Graduate School of Medicine, Japan
3.Department of Medical oncology, Hyogo Cancer Center, Akashi, Japan
Audio / 音訊檔
Category / 主題分類
Clinical Research
Keyword / 關鍵字
Datopotamab deruxtecan, ADC, treatment sequencing, adverse events